Evaluation of the effect of Eryngium billardieri in diabetic patients
Phase 2
Recruiting
- Conditions
- Type 2 diabetes.Diabetes mellitus due to underlying condition
- Registration Number
- IRCT20211229053563N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 76
Inclusion Criteria
All of the patients are over 20 years of age with type 2 diabetes, receiving oral medications (Metformin and/or Pioglitazone, etc), Hb.A1C > 7.5
Exclusion Criteria
Pregnancy and lactation, Creatinine clearance less than 30 ml/min, Severe liver failure, Patients treated with newer diabetes drugs (Incretin Mimetics and SGLT2 inhibitors), Hb.A1C <7.5
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method